The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Survival outcomes in elderly patients with plasma cell myeloma: The three-decade Eastern Cooperative Oncology Group (ECOG) experience.
E. L. Campagnaro
No relevant relationships to disclose
S. J. Jacobus
No relevant relationships to disclose
H. Uno
No relevant relationships to disclose
M. M. Oken
No relevant relationships to disclose
R. A. Kyle
No relevant relationships to disclose
S. V. Rajkumar
No relevant relationships to disclose
P. R. Greipp
No relevant relationships to disclose
D. H. Vesole
Consultant or Advisory Role - Celgene; Onyx
Honoraria - Celgene; Millennium
M. Weiss
No relevant relationships to disclose
R. Fonseca
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Genzyme; Lilly; Medtronic; Otsuka
Research Funding - Cylene; Onyx
H. M. Lazarus
Consultant or Advisory Role - Celgene (U)